Jupiter Endovascular secured an oversubscribed Series B financing exceeding $40 million, led by Sonder Capital. The funds will advance clinical trials and commercialization of their TFX technology.
Amount Raised
$40 Million
Round Type
Series B
Menlo ParkBiotechnologyHealth Caremedical devicesInvestors
Description
Jupiter Endovascular has closed an oversubscribed Series B financing round that exceeded its $40 million target. Led by Sonder Capital, this funding will help complete ongoing clinical trials and facilitate commercialization of their TFX technology. The financing highlights investor confidence in their innovative approach to endovascular medicine. The TFX platform aims to enhance stability and control during catheter interventions.
Quick answer
Jupiter Endovascular raised $40 Million in a Series B round, dated October 7, 2025. Investors: Senvest Management, LB Investment and Sonder Capital. Jupiter Endovascular is based in Menlo Park, California, United States.
- How much did Jupiter Endovascular raise?
- Jupiter Endovascular raised $40 Million in a Series B round on October 7, 2025.
- Who invested in Jupiter Endovascular?
- Senvest Management, LB Investment and Sonder Capital are named as investors in this round.
- What does Jupiter Endovascular do?
- Jupiter Endovascular is a medical technology startup developing the “endoportal procedure,” a new class of endovascular interventions using Endoportal Control to bring the precision and control of direct surgical access..
- Where is Jupiter Endovascular based and how big is it?
- Jupiter Endovascular is based in Menlo Park, California, United States. Fundz records about 45 employees.
- Who are the decision-makers at Jupiter Endovascular?
- Fundz holds 2 contacts at Jupiter Endovascular. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in medical devices and Biotechnology around the same time
Companies in the same sectors as Jupiter Endovascular that raised within 45 days of this round, from Fundz verified event records.
- Cornerstone Robotics raised $200M (Funding Round) on November 10, 2025.
- MoleSense raised $182K (Grant) on October 28, 2025.
- Polyembo raised an undisclosed amount (Funding Round) on October 24, 2025.
- Anteris Technologies raised $11M on October 23, 2025.
- SecondWave Systems raised an undisclosed amount (Series A) on October 23, 2025.
- CoMind raised $102M (Funding Round) on October 20, 2025.
Who to call at Jupiter Endovascular, and when
A new round usually means Jupiter Endovascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Jupiter Endovascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jupiter Endovascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jupiter Endovascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jupiter Endovascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansJupiter Endovascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.